Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antiviralsAna Lleò, Massimo Colombo, Andrea Aglitti et al.|Digestive and Liver Disease|2018Cited by 63
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Pietro Lampertico, Roberta D’Ambrosio et al.|Journal of Hepatology|2020Cited by 57
High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinomaMarcello Persico, Savino Bruno, Andrea Aglitti et al.|Alimentary Pharmacology & Therapeutics|2018Cited by 33
IFN-free DAA treatment of cirrhotic HCV patients with or without history of HCC: a multicenter prospective trial in ItalyAngelo Sangiovanni, Pietro Lampertico, Eleonora Alimenti et al.|Journal of Hepatology|2018Cited by 7
SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: a prospective multi-centric Italian studyAna Lleò, Savino Bruno, Andrea Aglitti et al.|Journal of Hepatology|2018Cited by 2